Traws Pharma Cash Flow Statement (2012-2025) | TRAW

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
Share-based Compensation (Quarter)	0.07M	0.06M	0.18M	0.26M	0.30M	0.24M	0.29M	0.33M	0.34M	0.27M	0.36M	0.33M	0.33M	0.38M	0.34M	0.33M	0.16M	0.10M	0.14M	0.33M
Gains from Sales and Divestitures (Quarter)							0.03M	0.03M	0.04M	0.04M	0.03M
Gains from Investment Securities (Quarter)	0.37M	-0.43M	0.40M		718.00	0.26M	1.91M			0.48M	2.18M			0.31M	0.43M		0.20M	-0.15M	0.00M	-26.57M
Non-cash Items (Quarter)	0.04M	0.05M	0.03M	0.52M	0.01M	2.17M	1.72M	0.23M	0.39M	0.46M	1.24M	0.02M	1.12M	1.13M	1.60M	2.70M	0.20M	0.41M	0.41M	0.46M
Cash from Operations (Quarter)	-6.65M	-4.31M	-4.27M	-4.26M	-4.30M	-4.21M	-3.90M	-3.88M	-4.54M	-4.49M	-4.47M	-4.43M	-4.42M	-9.85M	-11.48M	-4.04M	-5.44M	-5.98M	-4.01M	-2.76M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.04M
Change in Working Capital
Change in Receivables (Quarter)	0.00M	-0.01M	0.00M	-0.00M	-0.00M				-0.01M		0.00M					-0.36M	-0.11M	-0.33M	0.67M	1.80M
Change in Account Payables (Quarter)	-0.84M	0.30M	-0.24M	-1.29M	0.36M	-0.12M	0.76M	0.10M	1.04M	0.17M	1.08M	-0.53M	0.95M	-0.39M	-0.70M	0.79M	-0.60M	-3.00M	0.52M	2.47M
Change in Accured Expenses (Quarter)	-1.85M	-0.13M	-0.23M	0.38M	-0.53M	0.63M	0.12M	0.61M	0.14M	-0.73M	-0.07M	0.07M	-0.75M	-4.08M	-0.86M	0.47M	-0.60M	0.07M	0.19M	2.71M
Other Working Capital Changes (Quarter)	0.20M	0.01M	0.00M	-0.03M	0.25M	-0.36M	0.89M	-1.00M			-0.31M	1.43M	-0.08M	0.07M	0.02M	-0.06M	0.02M	0.02M	0.02M	-2.16M
Investing Activities
Capital Expenditures (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
Financing Activities
Other financing activities (Quarter)																	0.12M	0.16M	0.18M	1.94M
Cash from Financing Activities (Quarter)	35.64M	0.01M	19.94M	-0.04M												19.98M	0.01M	3.10M	-0.06M	0.16M
Additional items
Exchange Rate Effect (Quarter)	-0.02M	0.00M	-0.01M	-0.01M	-0.01M	-0.02M	-0.02M	0.03M	0.01M	-0.00M	-0.00M	0.01M	-0.01M	-0.00M		-0.01M	0.02M	0.03M	-0.00M
Change in Cash (Quarter)	28.98M	-4.30M	15.67M	-4.31M	-4.30M	-4.23M	-3.92M	-3.86M	-4.54M	-4.49M	-4.49M	-4.42M	-4.43M	0.50M	-11.48M	15.93M	-5.40M	-2.86M	-6.66M	-2.60M
Free Cash Flow (Quarter)	-6.65M	-4.31M	-4.27M	-4.26M	-4.30M	-4.21M	-3.90M	-3.88M	-4.54M	-4.49M	-4.47M	-4.43M	-4.42M	-9.85M	-11.48M	-4.04M	-5.44M	-5.98M	-4.01M	-2.76M
Net Cash Flow (Quarter)	29.00M	-4.30M	15.68M	-4.30M	-4.30M	-4.21M	-3.90M	-3.88M	-4.54M	-4.49M	-4.47M	-4.43M	-4.42M	-9.85M	-11.48M	15.94M	-5.42M	-2.88M	-4.07M	-2.60M

Research Tools

Traws Pharma Cash Flow Statement (2012-2025) | TRAW

Create an account

Sign In

Reset Password